リコンビナント
RabMAb

Anti-CrkL (phospho Y207) 抗体 [EP270Y] (ab52908)

製品の概要

  • 製品名
    Anti-CrkL (phospho Y207) antibody [EP270Y]
    CrkL 一次抗体 製品一覧
  • 製品の詳細
    Rabbit monoclonal [EP270Y] to CrkL (phospho Y207)
  • 特異性
    ab52908 only detects CrkL phosphorylated on Tyrosine 207.
  • アプリケーション
    適用あり: WB, IPmore details
    適用なし: Flow Cyt or IHC-P
  • 種交差性
    交差種: Mouse, Human
  • 免疫原

    A synthetic phospho peptide corresponding to residues surrounding Tyr207 of human CrkL

  • ポジティブ・コントロール
    • WB: K562 cell lysates
  • 特記事項

    This product is a recombinant rabbit monoclonal antibody.

     

    Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents

製品の特性

関連製品

アプリケーション

Our Abpromise guarantee covers the use of ab52908 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB 1/50000. Detects a band of approximately 39 kDa (predicted molecular weight: 34 kDa).
IP 1/50.
  • 追加情報
    Is unsuitable for Flow Cyt or IHC-P.
  • ターゲット情報

    Anti-CrkL (phospho Y207) antibody [EP270Y] 画像

    • All lanes : Anti-CrkL (phospho Y207) antibody [EP270Y] (ab52908) at 1/50000 dilution

      Lane 1 : (A) K562 cell lysates untreated
      Lane 2 : (B) K562 cell lysates treated with AP

      Lysates/proteins at 10 µg per lane.


      Predicted band size : 34 kDa
      Observed band size : 37 kDa (why is the actual band size different from the predicted?)

    Anti-CrkL (phospho Y207) antibody [EP270Y] (ab52908) 使用論文

    This product has been referenced in:
    • Ouellette SB  et al. A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance. PLoS One 11:e0161748 (2016). Read more (PubMed: 27598410) »
    • Li J  et al. Inhibition of 32Dp210 cells harboring T315I mutation by a novel derivative of emodin correlates with down-regulation of BCR-ABL and its downstream signaling pathways. J Cancer Res Clin Oncol N/A:N/A (2014). Human . Read more (PubMed: 25217883) »

    See all 6 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab52908.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    登録